Swiss Federal Institute of Technology, Switzerland

Plasma protein biomarker discovery and the PeptideAtlas

European Bioinformatics Institute, UK

Bioinformatics Infrastructure for Proteomics: Status of Database and Standards Developmen

Cancer Research UK Clinical Centre, Leeds

New Markers in Renal Cancer and a Route to the Clinic

Lund University, Sweden

Diagnostic and predictive serum biomarkers in oncology

UCD Conway Institute, Ireland
Protein Arrays

Vanderbilt University, USA

Direct Molecular Imaging and Profiling of Cancer Tissue Using Mass Spectrometry

Danish Centre for Translational Breast Cancer Research, Denmark

Proteomic Analysis of the Tumor-Host Microenvironment

Broad Institute of MIT and Harvard, USA (confirmed)

Progress Toward a Biomarker Discovery-to-Development Pipeline in Clinical Proteomics

Fred Hutchinson Cancer Research Center, USA

Cancer Biomarkers

Advanced Technology Center, National Cancer Institute, USA

Tissue Microarrays and Image Analysis

INSERM-University of Lille, France
Cell Signalling Proteomics

Biocenter of the Medical University Innsbruck, Austria

Analysis of MAPK signaling by Phosphoproteomics and Chemical Genetics

Royal College of Surgeons in Ireland, Ireland

Bioethics Session: “Biological Collections: Who Owns and Who Profits?”

Cancer Research UK Beatson Laboratories, UK

Signalling Networks and Systems Biology

Technical University of Munich
A quantitative chemical proteomics approach reveals novel modes of action of clinical

ABL kinase inhibitor

F. Hoffmann-La Roche, Switzerland

Biomarker Discovery in Drug Development

UCD Conway Institute, Ireland

The Cocaine and Amphetamine-Regulated Transcript (CART) is an Independent Marker of Breast Cancer Outcome and Predicts Response to Tamoxifen

KuDOS Pharmaceuticals, UK

Proteomics in Anti-Cancer Drug Development

UCD Conway Institute, Ireland

High-Throughput Identification of Alternative Splice Isoforms from Proteomic Data

MD Anderson Cancer Center, USA

Tumour Targeting

Fred Hutchinson Cancer Research Center, USA

Integrated Pipeline for Mass Spectrometry-Based Discovery and Confirmation of Protein Biomarkers Demonstrated in a Mouse Model of Breast Cance

University of Uppsala, Sweden

A Human Protein Atlas

Aperio, USA

Automated Analysis of Immunohistochemical Staining

Dana-Farber Cancer Institute, USA
Computational Approaches to Creating Network Models

Applied Genomics, USA

Immunohistochemical Surrogates of Gene Expression Profiles

Ludwig Institute for Cancer Research, Royal Melbourne Hospital, Australia

Insights into Oncogenic Mechanisms via Proteomic Analysis

Royal College of Surgeons in Ireland, Ireland

Bioethics session

Memorial Sloan-Kettering Cancer Center, USA

Blood-Based Exoprotease Activities as Biomarkers for Cancer

Max Planck Institute for Biochemistry, Germany

Protein Phosphorylation and Signalling